Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Vivoryon & Nordic Bioscience Enter into R&D Collaboration (2020-01-14)
Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) and Nordic Bioscience, announced today an agreement to collaborate for the clinical development of PQ912 for Alzheimer’s Disease (AD). In addition to taking on the role as CRO (Clinical Research ...
NorthSea Therapeutics €36m Series B Round Led by venBio (2020-01-08)
> Two new US investors; lead investor, venBio Partners and Sofinnova Investments, join syndicate of existing investors > Richard Gaster, M.D., Ph.D., Principal at venBio Partners, and Maha Katabi, Ph.D., CFA, Partner at Sofinnova Investments join the Board > ...
Therachon Spinout VectivBio Launches with $35m Financing (2020-01-07)
–VectivBio will focus on rare diseases with well-defined biology that can be targeted with transformational therapeutics– –Key leaders from Therachon building another global, fully integrated company– –Topline results for Phase 2 trials of lead product candid...
Novo REPAIR Fund Invests $12m in Mutabilis & IBT Vaccines (2020-01-06)
> The Fund has now committed a total of USD 48 million to eight companies > REPAIR to adjust strategic scope for 2020 > Global call for investment proposals will open during summer of 2020 Today, the Novo Holdings REPAIR Impact Fund announced a EUR 7 [US...
Savara: Private Placement of $26.8m (up to $75m Potentially) (2019-12-20)
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that it has entered into a definitive agreement for a private placement with institutional investors to purchase an aggregate of 9,569,430 shares of common stock and, in lieu of shares of c...
Genmab & CureVac Partner for mRNA-based Antibody Drugs (2019-12-19)
> Genmab and CureVac enter broad strategic partnership > Companies to conduct joint research on first program; option for Genmab to initiate three additional programs during 5-year research term > Genmab will provide CureVac with a USD 10 million upfront paym...
Bone Therapeutics Appoints Miguel Forte as CEO (2019-12-19)
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address highly unmet medical needs in orthopaedics and bone diseases, today announces the appointment of Dr...
Zelluna Immunotherapy Promotes CSO Namir Hassan to CEO (2019-12-19)
Zelluna Immunotherapy, the biopharma company developing T-cell receptor (TCR) guided adoptive cell therapy products for treatment of multiple solid cancers, today announces the appointment of Namir Hassan as chief executive officer (CEO). “At this stage of Zell...
Genomill Health Closes Financing Round Led by Voima Ventures (2019-12-18)
Genomill Health closes a financing round led by a deep tech VC Voima Ventures to expand its novel and disruptive technology, focusing on efficient use of NGS (next generation sequencing) in liquid biopsies for cancer diagnostics. Genomill Health announces toda...
BC Platforms Closes $15m Series C, Partners with Iqvia (2019-12-18)
BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™ (NYSE: IQV). The round was led by IQVIA in conjunction with Debiopharm I...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

Start here with the latest News!

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top